Anticoagulants in cirrhotic patients: Controversies and certainties in PVT management

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 9, Issue 3, 2011, Pages 183-189

  Ponziani, Francesca R ^a   Zocco, Maria A ^a   Tortora, Annalisa ^a   Gasbarrini, Giovanni ^b   Gasbarrini, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b Fondazione Ricerca in Medicina   (Italy)

Author keywords

Anticoagulants; Bleeding; Bowel ischemia; Coagulation system; Factor X inhibitors; Heparin; INR; Liver cirrhosis; Portal vein thrombosis; Portal vein thrombosis prevention; Pro thormbotic disorders; Recanalization; Vitamin k antagonists; Warfarin

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ENOXAPARIN; NADROPARIN; PLACEBO;

ANTICOAGULANT THERAPY; CLINICAL PRACTICE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PORTAL VEIN THROMBOSIS; REVIEW;

ANTICOAGULANTS; DISEASE MANAGEMENT; DRUG EVALUATION; HUMANS; LIVER CIRRHOSIS; PORTAL VEIN; VENOUS THROMBOSIS;

EID: 80052189600     PISSN: 18715257     EISSN: 18756182     Source Type: Journal    
DOI: 10.2174/187152511797037448     Document Type: Review

References (41)

1. Okuda, K.; Ohnishi, K.; Kimura, K.; Matsutani, S.; Sumida, M.;Goto, N.; Musha, H.; Takashi, M.; Suzuki, N.; Shinagawa, T. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology, 1985, 89(2), 279-286.
2. Francoz, C.; Belghiti, J.; Vilgrain, V.; Sommacale, D.; Paradis, V.;Condat, B.; Denninger, M.H.; Sauvanet, A.; Valla, D.; Durand, F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut, 2005, 54(5), 691-697.
3. Amitrano, L.; Guardascione, M.A.; Brancaccio, V.; Margaglione, M.; Manguso, F.; Iannaccone, L.; Grandone, E.; Balzano, A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J. Hepatol., 2004, 40(5), 736-741.
4. Harmanci, O.; Bayraktar, Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J. Gastroenterol., 2007, 13(18), 2535-2540.
5. Webster, G.J.; Burroughs, A.K.; Riordan, S.M. Review article:portal vein thrombosis -- new insights into aetiology and management. Aliment. Pharmacol. Ther., 2005, 21(1), 1-9.
6. Northup, P.G; Sundaram, V.; Fallon, M.B.; Reddy, K.R.; Balogun, R.A. Sanyal A.J. Anstee, Q.M.; Hoffman, M.R.; Ikura, Y.; Caldwell, S.H. Coagulation in Liver Disease Group. Hyper-coagulation and thrombophilia in liver disease. J. Thromb. Haemost., 2008, 6(1), 2-9.
7. Sobhonslidsuk, A.; Reddy, K.R. Portal vein thrombosis: a concise review. Am. J. Gastroenterol., 2002, 97(3), 535-541.
8. Sogaard, K.K.; Astrup, L.B.; Vilstrup, H.; Gronbaek, H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol., 2007, 7, 34.
9. Bayraktar, Y.; Harmanci, O. Etiology and consequences of thrombosis in abdominal vessels. World J. Gastroenterol., 2006, 12(8), 1165-1174.
10. Ponziani, F.R.; Zocco, M.A.; Campanale, C.; Rinninella, E.; Tortora, A.; Di Maurizio, L.; Bombardieri, G.; De Cristofaro, R.; De Gaetano, A.M.; Landolfi, R.; Gasbarrini, A. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J. Gastroenterol., 2010, 16(2), 143-155.
11. Hoekstra, J.; Janssen, H.L. Vascular liver disorders (II): portal vein thrombosis. Neth. J. Med., 2009, 67(2), 46-53.
12. Valla, D.C.; Condat, B. Portal vein thrombosis in adults:pathophysiology, pathogenesis and management. J. Hepatol., 2000, 32(5), 865-871.
13. Senzolo, M.; Ferronato, C.; Burra, P.; Sartori, M.T. Anti-coagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern. Emerg. Med., 2009, 4(2), 161-162; author reply 163-164.
14. Amitrano, L.; Guardascione, M.A.; Brancaccio, V.; Iannaccone, L.;Ames, P.R.; Balzano, A. Portal and mesenteric venous thrombosis in cirrhotic patients. Gastroenterology, 2002, 123(4), 1409-1410.
15. Ponziani, F.; De Stefano, V.; Gasbarrini, A. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Medit. J. Hemat. Infect. Dis., 2009, 1(3): e2009033.
16. Garcia-Fuster, M.J.; Abdilla, N.; Fabia, M.J.; Fernandez, C.; Oliver, V.; Forner, M.J. [Venous thromboembolism and liver cirrhosis]. Rev. Esp. Enferm. Dig., 2008, 100(5), 259-262.
17. Martinelli, I.; Franchini, M.; Mannucci, P.M. How I treat rare venous thromboses. Blood, 2008, 112(13), 4818-4823.
18. Spahr, L.; Boehlen, F.; De Moerloose, P.; Hadengue, A. Anti-coagulants in portal vein thrombosis: don't be so shy! Blood, 2009, 113(20), 5031-5032; author reply 5032.
19. Northup, P.G.; McMahon, M.M.; Ruhl, A.P.; Altschuler, S.E.;Volk-Bednarz, A.; Caldwell, S.H.; Berg, C.L. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am. J. Gastroenterol., 2006, 101(7), 1524-1528.
20. Gulley, D.; Teal, E.; Suvannasankha, A.; Chalasani, N.; Liangpunsakul, S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig. Dis. Sci., 2008, 53(11), 3012-3017.
21. Tripodi, A.; Chantarangkul, V.; Mannucci, P.M. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br. J. Haematol., 2009, 147(1), 77-82.
22. DeLeve, L.D.; Valla, D.C.; Garcia-Tsao, G. Vascular disorders of the liver. Hepatology, 2009, 49(5), 1729-1764.
23. Romero-Gömez, M.; Gutierrez-Tous, R.; Delgado-Mije, D.Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding. Gastroenterology, 2002, 122(7), 2095.
24. Amitrano, L.; Guardascione, M.A.; Menchise, A.; Martino, R.;Scaglione, M.; Giovine, S., Romano, L.; Balzano, A. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J. Clin. Gastroenterol., 2010, 44(6), 448-451.
25. Amitrano, L.; Guardascione, M. Management of portal vein thrombosis in cirrhotic patients. Medit. J. Hemat. Infect. Dis., 2009; 1(3), e2009014.
26. Sarin, S.K.; Sollano, J.D.; Chawla, Y.K.; Amarapurkar, D.; Hamid S.; Hashizume, M.; Jafri, W.; Kumar, A.; Kudo, M.; Lesmana, L.A.; Sharma, B.C.; Shiha, G.; Janaka de Silva, H. Members of the APASL Working Party on Portal Hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int., 2006, 26(5), 512-519.
27. Fimognari, F.; Violi, F. Should we use anticoagulant drugs to treat portal vein thrombosis in patients with liver cirrhosis? Int. Emerg. Med., 2009, 4(2),163-164.
28. Fimognari, F.L.; Violi, F. Portal vein thrombosis in liver cirrhosis.Intern. Emerg. Med., 2008, 3(3), 213-218.
29. Belli, L.; Romani, F.; Sansalone, C.V.; Aseni, P.; Rondinara, G. Portal thrombosis in cirrhotics. A retrospective analysis. Ann. Surg., 1986, 203(3), 286-291.
30. Chawla, Y.; Duseja, A.; Dhiman, R.K. Review article: the modern management of portal vein thrombosis. Aliment. Pharmacol. Ther., 2009, 30(9), 881-894.
31. Orloff, M.J.; Orloff, M.S.; Girard, B.; Orloff, S.L. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J. Am. Coll. Surg., 2002, 194(6), 717-728; discussion 728-730.
32. De Franchis, R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol., 2005, 43, 167-176.
33. Connolly, G.C.; Chen, R.; Hyrien, O.; Mantry, P.; Bozorgzadeh, A.; Abt, P.; Khorana, A.A. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb. Res., 2008, 122(3), 299-306.
34. Amitrano, L.; Guardascione, M.A.; Scaglione, M.; Pezzullo, L.; Sangiuliano, N.; Armellino, M.F.; Manguso, F.;Margaglione, M.; Ames, P.R.; Iannaccone, L.; Grandone, E.; Romano, L.; Balzano, A. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am. J. Gastroenterol., 2007, 102(11), 2464-2470.
35. Garcia-Pagan, J.C.; Hernandez-Guerra, M; Bosch, J. Extrahepatic portal vein thrombosis. Semin. Liver. Dis., 2008, 28(3), 282-292.
36. Rajani, R.; Björnsson, E.; Bergquist, A.; Danielsson, A.; Gustavsson, A.; Grip, O.; Melin, T.; Sangfelt, P.; Wallerstedt, S.; Almer, S. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment. Pharmacol. Ther., 2010, 32(9), 1154-1162.
37. Zocco, M.A.; Di Stasio, E; De Cristofaro, R.; Novi, M.; Ainora,M.E.; Ponziani, F.; Riccardi, L.; Lancellotti, S.; Santoliquido, A.; Flore, R.; Pompili, M.; Rapaccini, G.L.; Tondi, P.; Gasbarrini, G.B.; Landolfi, R.; Gasbarrini, A. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J. Hepatol., 2009, 51(4), 682-689.
38. Hidajat, N; Stobbe, H; Griesshaber, V; Felix, R; Schroder, R.J; Imaging and radiological interventions of portal vein thrombosis. Acta Radiol., 2005, 46, 336-343.
39. Condat, B.; Pessione, F.; Hillaire, S.; Denninger, M.H.; Guillin, M.C.; Poliquin, M.; Hadengue, A.; Erlinger, S; Valla, D. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology, 2001, 120, 490-497.
40. Zecchini, R.; Ferrari, A.; Bernabucci, V.; Lei, B.; Vukotic, R.; De Maria, N.; Schepis, F.; Marietta, M.; Fornaciari, G.; Schianchi, S.; Villa, E. Anticoagulant therapy is safe and effective n prevent- ing portal vein thrombosis (PVT) in advanced cirrhotic patients: a prospective randomized controlled study. J. Hepatol., 2010, 52, S460.
41. Novi, M.; Lauritano, E.C.; Piscaglia, A.C.; Barbaro, B., Zocco, M.A.; Pompili, M.; Gasbarrini, A. Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma. Am. J. Gastroenterol., 2009, 104(7), 1852-1854.